相关实验视频

Updated: May 28, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

评估环素D1表达:子宫内膜癌的预后价值和功能洞察:在研究中

Marcin Szymański¹, Dominika Jerka¹, Klaudia Bonowicz^1,2

¹Department of Histology and Embryology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-092 Bydgoszcz, Poland.

International journal of molecular sciences

|February 13, 2025

概括

环素D1失调影响子宫内膜癌 (EC) 的进展. 了解它在EC亚型中的作用可能会导致针对这种常见女性癌症的侵袭性和耐药性形式的向治疗.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

子宫内膜癌 (EC) 是一种全球普遍存在的恶性瘤,其发病率与肥胖和2型糖尿病有关.
欧洲细胞表现出多种不同的组织学亚型 (I型与I型对比). 类型II) 的预后不同.
细胞循环失调,涉及循环素依赖激酶 (CDK) 和循环素D1 (CCND1),与EC进展有关.

研究的目的:

为了研究在子宫内膜癌中Cyclin D1表达的预后意义.
为了将Cyclin D1水平与EC亚型,组织病理学和临床结果相关联.
探索针对个性化EC疗法的Cyclin D1/CDK4/6通路的潜力.

主要方法:

在EC患者样本中对Cyclin D1表达的免疫组织化学分析.
整合患者数据与癌症基因组图谱 (TCGA) 数据库.
分子,组织病理学和临床数据的相关性,以评估预后价值.

主要成果:

环素D1的过度表达与早期子宫内膜腺癌有关.
较低的环素D1表达与激进的,高度的EC亚型如血清癌相关.
赛克林D1的调节失调会影响整个亚型的EC进展和复发.

结论:

环素D1在子宫内膜癌的进展和亚型行为中起着重要作用.
评估Cyclin D1表达可能有助于预测EC预后.
这些发现支持对个人化EC治疗策略的CDK抑制剂的进一步研究,特别是在攻击性亚型中.

关键词:

CCND1 一个人的生活这是子宫内膜癌的癌症.预后因素是一个预后因素.

更多相关视频

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...